Theravance Biopharma Inc
(NAS:TBPH)
$
16.87
+0.020 (+0.12%)
Market Cap: 874.34 Mil
Enterprise Value: 520.18 Mil
PE Ratio: 7.67
PB Ratio: 2.99
GF Score: 72/100 Theravance Biopharma Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
May 13, 2021 / 06:45PM GMT
Release Date Price:
$18.72
(-0.79%)
Tazeen Ahmad
BofA Securities, Research Division - VP
Good afternoon, everybody. Thanks so much for joining us at the Bank of America Healthcare Conference. It's my pleasure to have our next presenting company with me Theravance Biopharma. I have a long history with Theravance. You guys are one of the longest-running coverage companies that I've had going back over a decade, I think. So Rick, it's good to see you always. Rick Winningham, of course, CEO of Theravance Biopharma.
Rick E. Winningham
Theravance Biopharma, Inc. - Chairman & CEO
Great to see you, Tazeen, and thanks so much for the invitation.
Tazeen Ahmad
BofA Securities, Research Division - VP
Rick, you have a couple of colleagues with you on this call. I'll let you introduce them.
Rick E. Winningham
Theravance Biopharma, Inc. - Chairman & CEO
Sure. Joining me today are Andrew Hindman, our CFO; and Rick Graham, who's our Senior Vice President of Development and is responsible for the development
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot